![](/img/cover-not-exists.png)
574 Pharmacokinetics and metabolism of CPT-11 (Campto®) combined with capecitabine (Xeloda®) in patients with advanced colorectal cancer: altered disposition of the metabolites SN-38 and SN-38 glucuronide?
M. Czejka, J. Schueller, E. Ostermann, K. Hauer, U. ZeleniVolume:
1
Year:
2003
Language:
english
DOI:
10.1016/s1359-6349(03)90606-9
File:
PDF, 165 KB
english, 2003